Human Metabolome Technologies (6090) · PolicyReframed
Contributing to the SDGs through Research and Development and Health Improvement
First written in FY2021. 1 of 2 entries say "Reframed", first in FY2024. Latest entry: FY2024.
2entries
4years
0from disclosures
How it moved
Same theme, other companies
SDG contributions through research and development and health improvementA theme 2 companies write about · 0 as a headwind · 2 as a tailwind
Human Metabolome Technologies moved to the "Worse" side of this theme in 2024.
0 other companies' latest entry also says "Reframed".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2024ReframedAnnual report
「We aim to achieve both a sustainable society and sustainable growth for our group.」
The company organized its previous policy of contributing to the SDGs into an overall sustainability framework that includes discussions of issues by the board of directors, human capital initiatives, and risk management. - FY2021First statedAnnual report
「Through these activities, we will promote scientific research in the industrial sector and contribute to improving technological capabilities (SDG 9). Through the commercialization of products and services by client companies and our group, we aim to contribute to the early warning, mitigation, and management of health risk factors, the prevention and response to infectious diseases, and improvements in mental health (SDG 3).」
The company for the first time explicitly linked scientific research and improved technological capabilities to SDG 9, and improvements in health risk factors, infectious diseases, and mental health to SDG 3.